In contrast, HK L-137 had no effect on the IL-10 expression level in the spleen (Fig. 9L) HK L-137 at low dose also alleviated the reduction in IFN-β mRNA level in the MetS group (Fig. 9M). This evidence concerns the gene IFNB1 and metabolic syndrome.